Diffuse Large B-Cell Lymphoma Companies are involved in targeted therapeutics development with respective active and inactive ...

Leaked data showed that Pfizer’s mevrometostat has strong therapeutic potential in metastatic castration-resistant prostate ...

Among older adults with classical Hodgkin lymphoma, frontline N-AVD has been found to be highly effective and well-tolerated.

Non-transplant salvage therapy for low-risk relapsed/refractory pediatric classical Hodgkin lymphoma (cHL) had high rates of progression-free (PFS) and overall survival (OS) at 3-5 years ...

Lymphocyte-predominant Hodgkin's lymphoma (LPHL) is a rare disease, which differs substantially from classical Hodgkin's lymphoma (cHL) with regard to histopathology and clinical course.

The FDA has approved Adcetris (brentuximab vedotin) for use in combination with lenalidomide and rituximab to treat patients with relapsed/refractory LBCL after 2 or more lines of systemic therapy who ...

Study shows that using immune checkpoint inhibitors before allogeneic transplantation improves overall survival and ...

On Thursday, Jones announced that her cancer, diagnosed earlier this month, is Stage 4 Hodgkin’s Lymphoma. She said she is using the strength she once found on the basketball court to continue living.